{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:33:30Z","timestamp":1773423210892,"version":"3.50.1"},"reference-count":8,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,29]]},"DOI":"10.7759\/cureus.61317","type":"journal-article","created":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T16:58:21Z","timestamp":1717001901000},"source":"Crossref","is-referenced-by-count":1,"title":["Pemphigus Vulgaris Treated With Ibrutinib: A Case Report"],"prefix":"10.7759","author":[{"given":"Abdulellah I","family":"Aleissa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadeel F","family":"Alsulaimani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tarek","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-2706","article-title":"Pemphigus vulgaris and pemphigus foliaceus: differences in epidemiology and mortality","volume":"97","author":"Kridin K","year":"2017","unstructured":"Kridin K, Zelber-Sagi S, Bergman R. Pemphigus vulgaris and pemphigus foliaceus: differences in epidemiology and mortality. Acta Derm Venereol. 2017, 97:1095-9. 10.2340\/00015555-2706","journal-title":"Acta Derm Venereol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7964","article-title":"Pemphigus vulgaris - approach and management","volume":"18","author":"Popescu IA","year":"2019","unstructured":"Popescu IA, Statescu L, Vata D, Porumb-Andrese E, Patrascu AI, Grajdeanu IA, Solovastru LG. Pemphigus vulgaris - approach and management. Exp Ther Med. 2019, 18:5056-60. 10.3892\/etm.2019.7964","journal-title":"Exp Ther Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.26","article-title":"Pemphigus","volume":"3","author":"Kasperkiewicz M","year":"2017","unstructured":"Kasperkiewicz M, Ellebrecht CT, Takahashi H, Yamagami J, Zillikens D, Payne AS, Amagai M. Pemphigus. Nat Rev Dis Primers. 2017, 3:17026. 10.1038\/nrdp.2017.26","journal-title":"Nat Rev Dis Primers"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-4362.2001.01247.x","article-title":"The incidence of pemphigus in the southern region of Saudi Arabia","volume":"40","author":"Tallab T","year":"2001","unstructured":"Tallab T, Joharji H, Bahamdan K, Karkashan E, Mourad M, Ibrahim K. The incidence of pemphigus in the southern region of Saudi Arabia. Int J Dermatol. 2001, 40:570-2. 10.1046\/j.1365-4362.2001.01247.x","journal-title":"Int J Dermatol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.708071","article-title":"Bruton tyrosine kinase inhibition and its role as an emerging treatment in pemphigus","volume":"8","author":"Patsatsi A","year":"2021","unstructured":"Patsatsi A, Murrell DF. Bruton tyrosine kinase inhibition and its role as an emerging treatment in pemphigus. Front Med (Lausanne). 2021, 8:708071. 10.3389\/fmed.2021.708071","journal-title":"Front Med (Lausanne)"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57101080","article-title":"An updated review of pemphigus diseases","volume":"57","author":"Malik AM","year":"2021","unstructured":"Malik AM, Tupchong S, Huang S, Are A, Hsu S, Motaparthi K. An updated review of pemphigus diseases. Medicina (Kaunas). 2021, 57:10.3390\/medicina57101080","journal-title":"Medicina (Kaunas)"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2015.06.005","article-title":"Oral mucosal manifestations of autoimmune skin diseases","volume":"14","author":"Mustafa MB","year":"2015","unstructured":"Mustafa MB, Porter SR, Smoller BR, Sitaru C. Oral mucosal manifestations of autoimmune skin diseases. Autoimmun Rev. 2015, 14:930-51. 10.1016\/j.autrev.2015.06.005","journal-title":"Autoimmun Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14463","article-title":"Comorbidities and inpatient mortality for pemphigus in the U.S.A","volume":"174","author":"Hsu DY","year":"2016","unstructured":"Hsu DY, Brieva J, Sinha AA, Langan SM, Silverberg JI. Comorbidities and inpatient mortality for pemphigus in the U.S.A. Br J Dermatol. 2016, 174:1290-8. 10.1111\/bjd.14463","journal-title":"Br J Dermatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256686-pemphigus-vulgaris-treated-with-ibrutinib-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,29]],"date-time":"2024-05-29T16:58:23Z","timestamp":1717001903000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256686-pemphigus-vulgaris-treated-with-ibrutinib-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,29]]},"references-count":8,"URL":"https:\/\/doi.org\/10.7759\/cureus.61317","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,29]]}}}